Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Xue, Nina ^a   Zhou, Qin ^a   Ji, Ming ^a   Jin, Jing ^a   Lai, Fangfang ^a   Chen, Ju ^a   Zhang, Mengtian ^b   Jia, Jing ^b   Yang, Huarong ^b   Zhang, Jie ^b   Li, Wenbin ^c   Jiang, Jiandong ^a   Chen, Xiaoguang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Jiuzhang Biochemical Engineering Science and Technohgy Devehpment Co Ltd   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROGENIC ACID; IMMUNOLOGIC FACTOR;

ANIMAL; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; COCULTURE; DISEASE MODEL; DRUG EFFECT; GLIOBLASTOMA; HUMAN; IMMUNOLOGY; MACROPHAGE; MOUSE; PATHOLOGY; PHENOTYPE; RAW 264.7 CELL LINE; TREATMENT OUTCOME; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHLOROGENIC ACID; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; IMMUNOLOGIC FACTORS; MACROPHAGES; MICE; NEOPLASM TRANSPLANTATION; PHENOTYPE; RAW 264.7 CELLS; TREATMENT OUTCOME;

EID: 85008410738     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39011     Document Type: Article

References (49)

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 352, 987-996 (2005).
2. Lorger, M. Tumor microenvironment in the brain. Cancers 4, 218-243 (2012).
3. Benoit, M., Desnues, B. & Mege, J. L. Macrophage polarization in bacterial infections. J Immunol 181, 3733-3739 (2008).
4. Mantovani, A. & Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current opinion in immunology 22, 231-237 (2010).
5. Allavena, P., Sica, A., Solinas, G., Porta, C. & Mantovani, A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Critical reviews in oncology/hematology 66, 1-9 (2008).
6. Stout, R. D. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175, 342-349 (2005).
7. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164, 6166-6173 (2000).
8. Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nature reviews. Cancer 8, 618-631 (2008).
9. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in immunology 23, 549-555 (2002).
10. Steidl, C. et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. The New England journal of medicine 362, 875-885 (2010).
11. Chen, J. et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer cell 19, 541-555 (2011).
12. Ye, X. Z. et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 189, 444-453 (2012).
13. Zhang, M. et al. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. PloS one 11, e0153550 (2016).
14. Yin, Y., Huang, X., Lynn, K. D. & Thorpe, P. E. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer immunology research 1, 256-268 (2013).
15. Rolny, C. et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer cell 19, 31-44 (2011).
16. Coscia, M. et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. Journal of cellular and molecular medicine 14, 2803-2815 (2010).
17. Ma, J. et al. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC cancer 10, 112 (2010).
18. Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A. & Bradding, P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. The European respiratory journal 33, 118-126 (2009).
19. Comito, G. et al. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancerassociated fibroblasts. Oncotarget doi: 10.18632/oncotarget.9497 (2016)
20. Jia, X. et al. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs. Breast cancer research and treatment 148, 291-302 (2014).
21. Weiskopf, K. et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. The Journal of clinical investigation doi: 10.1172/JCI81603 (2016)
22. Ding, L. et al. Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages. Oncotarget 6, 36441-36455 (2015).
23. He, L. & Marneros, A. G. Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization. The Journal of biological chemistry 289, 8019-8028 (2014).
24. Boerjan, W., Ralph, J. & Baucher, M. Lignin biosynthesis. Annual review of plant biology 54, 519-546 (2003).
25. Xu, Y. et al. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflamm Res 59, 871-877 (2010).
26. Zhang, X. et al. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Injury 41, 746-752 (2010).
27. Shan, J. et al. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. International immunopharmacology 9, 1042-1048 (2009).
28. Wu, H. Z., Luo, J., Yin, Y. X. & Wei, Q. Effects of chlorogenic acid, an active compound activating calcineurin, purified from Flos Lonicerae on macrophage. Acta pharmacologica Sinica 25, 1685-1689 (2004).
29. Bandyopadhyay, G. et al. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinasedependent apoptosis in chronic myelogenous leukemic cells. Blood 104, 2514-2522 (2004).
30. Jin, U. H. et al. A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life sciences 77, 2760-2769 (2005).
31. Park, J. J., Hwang, S. J., Park, J. H. & Lee, H. J. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1alpha/AKT pathway. Cell Oncol (Dordr) 38, 111-118 (2015).
32. Xu, R., Kang, Q., Ren, J., Li, Z. & Xu, X. Antitumor Molecular Mechanism of Chlorogenic Acid on Inducting Genes GSK-3 beta and APC and Inhibiting Gene beta-Catenin. Journal of analytical methods in chemistry 2013, 951319 (2013).
33. Belkaid, A., Currie, J. C., Desgagnes, J. & Annabi, B. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer cell international 6, 7 (2006).
34. Feng, R. et al. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280, 27888-27895 (2005).
35. Matsunaga, K. et al. Inhibitory Effects of Chlorogenic Acid on Azoxymethane-induced Colon Carcinogenesis in Male F344 Rats. Asian Pac J Cancer Prev 3, 163-166 (2002).
36. Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature reviews. Immunology 11, 750-761 (2011).
37. Welch, J. S. et al. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. The Journal of biological chemistry 277, 42821-42829 (2002).
38. Fujiwara, Y. et al. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncology reports 26, 1533-1537 (2011).
39. Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. The Journal of clinical investigation 122, 787-795 (2012).
40. Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G. & Mantovani, A. Tumor associated macrophages and neutrophils in tumor progression. Journal of cellular physiology 228, 1404-1412 (2013).
41. Juhas, U., Ryba-Stanislawowska, M., Szargiej, P. & Mysliwska, J. Different pathways of macrophage activation and polarization. Postepy Hig Med Dosw (Online) 69, 496-502 (2015).
42. Hwang, S. J., Kim, Y. W., Park, Y., Lee, H. J. & Kim, K. W. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharidestimulated RAW 264.7 cells. Inflammation research : official journal of the European Histamine Research Society... [et al.] 63, 81-90 (2014).
43. Ohmori, Y. & Hamilton, T. A. Requirement for STAT1 in LPS-induced gene expression in macrophages. Journal of leukocyte biology 69, 598-604 (2001).
44. Kim, S. J. Curcumin suppresses the production of interleukin-6 in Prevotella intermedia lipopolysaccharide-activated RAW 264.7 cells. Journal of periodontal & implant science 41, 157-163 (2011).
45. Zhou, Y. et al. Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and its Signaling Pathways. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 36, 631-641 (2015).
46. Gao, S. et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. Journal of molecular and cellular cardiology 85, 131-139 (2015).
47. Iwanowycz, S., Wang, J., Altomare, D., Hui, Y. & Fan, D. Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory. The Journal of biological chemistry 291, 11491-11503 (2016).
48. Fujiwara, Y., Komohara, Y., Ikeda, T. & Takeya, M. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer science 102, 206-211 (2011).
49. Xue, N. et al. Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways. Current cancer drug targets 14, 671-683 (2014).